144 related articles for article (PubMed ID: 22804251)
1. Multiple eruptive plaque-like dermatofibromas during anti-TNFα treatment.
Caldarola G; Bisceglia M; Pellicano R
Int J Dermatol; 2013 May; 52(5):638-41. PubMed ID: 22804251
[No Abstract] [Full Text] [Related]
2. A case of eczematous and vesicular dermatitis during anti-TNFalpha therapy for rheumatoid arthritis.
Savoia F; Gaddoni G; Casadio C; Spadola G; Patrizi A; Giacomini F; Aldi M
G Ital Dermatol Venereol; 2011 Aug; 146(4):308-9. PubMed ID: 21785399
[No Abstract] [Full Text] [Related]
3. Biologic therapy for rheumatoid arthritis.
Klippel JH
N Engl J Med; 2000 Nov; 343(22):1640-1. PubMed ID: 11096174
[No Abstract] [Full Text] [Related]
4. Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept.
Kekow J; Welte T; Kellner U; Pap T
Arthritis Rheum; 2002 Mar; 46(3):843-4. PubMed ID: 11920425
[No Abstract] [Full Text] [Related]
5. Anti-tumor necrosis factor-alpha agents for rheumatoid arthritis: assessing longterm safety.
Hyrich KL; Silman AJ
J Rheumatol; 2006 May; 33(5):831-3. PubMed ID: 16652412
[No Abstract] [Full Text] [Related]
6. Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors.
Deng A; Harvey V; Sina B; Strobel D; Badros A; Junkins-Hopkins JM; Samuels A; Oghilikhan M; Gaspari A
Arch Dermatol; 2006 Feb; 142(2):198-202. PubMed ID: 16490847
[TBL] [Abstract][Full Text] [Related]
7. Anti-TNF-alpha therapies: they are all the same (aren't they?).
Mpofu S; Fatima F; Moots RJ
Rheumatology (Oxford); 2005 Mar; 44(3):271-3. PubMed ID: 15561736
[No Abstract] [Full Text] [Related]
8. Tumor necrosis factor-alpha blockade and the risk of vasculitis.
Guillevin L; Mouthon L
J Rheumatol; 2004 Oct; 31(10):1885-7. PubMed ID: 15468348
[No Abstract] [Full Text] [Related]
9. Interstitial granulomatous dermatitis in a patient with rheumatoid arthritis on etanercept.
Levine SD; Robinson M; Honda K; Nedorost S
Cutis; 2009 Jan; 83(1):50. PubMed ID: 19271571
[No Abstract] [Full Text] [Related]
10. Can tumor necrosis factor alpha blockade predispose to severe babesiosis?
Taiwo B; Lee C; Venkat D; Tambar S; Sutton SH
Arthritis Rheum; 2007 Feb; 57(1):179-81. PubMed ID: 17266091
[No Abstract] [Full Text] [Related]
11. Etanercept-associated right abducens nerve palsy in rheumatoid arthritis.
Lai CC; Hsiao KH; Chang YS; Tsai CY; Chou CT
Int J Rheum Dis; 2012 Oct; 15(5):e117-9. PubMed ID: 23083045
[No Abstract] [Full Text] [Related]
12. Sarcoidosis during anti-tumor necrosis factor-alpha therapy: no relapse after rechallenge.
van der Stoep D; Braunstahl GJ; van Zeben J; Wouters J
J Rheumatol; 2009 Dec; 36(12):2847-8. PubMed ID: 19966199
[No Abstract] [Full Text] [Related]
13. New-onset psoriasis associated with etanercept therapy.
Chen LA; Su LH; Chang YJ; Hsu YL; Tsai TH
J Dermatol; 2010 Apr; 37(4):378-80. PubMed ID: 20507411
[No Abstract] [Full Text] [Related]
14. Tumor necrosis factor inhibitors for rheumatoid arthritis.
Scott DL; Kingsley GH
N Engl J Med; 2006 Aug; 355(7):704-12. PubMed ID: 16914706
[No Abstract] [Full Text] [Related]
15. [Etanercept for therapy of rheumatoid arthritis].
Miyasaka N
Nihon Rinsho; 2005 Jan; 63 Suppl 1():521-5. PubMed ID: 15799411
[No Abstract] [Full Text] [Related]
16. Etanercept allergy and anaphylaxis.
Quismorio A; Brahmbhatt B; Houng M; Panush RS
J Rheumatol; 2012 Nov; 39(11):2225-6. PubMed ID: 23118296
[No Abstract] [Full Text] [Related]
17. Lichen striatus associated with etanercept treatment of rheumatoid arthritis.
Lora V; Kanitakis J; Latini A; Cota C
J Am Acad Dermatol; 2014 Apr; 70(4):e90-e92. PubMed ID: 24629374
[No Abstract] [Full Text] [Related]
18. Tumor necrosis factor inhibition: a part of the solution or a part of the problem of heart failure in rheumatoid arthritis?
Gabriel SE
Arthritis Rheum; 2008 Mar; 58(3):637-40. PubMed ID: 18311805
[No Abstract] [Full Text] [Related]
19. Cutaneous drug eruption with an interface dermatitis pattern due to anti-tumour necrosis factor-alpha agents: a relevant class-effect.
Garcovich S; Burlando M; Rongioletti F; Garcovich A; Parodi A; Amerio P
Acta Derm Venereol; 2010 May; 90(3):311-2. PubMed ID: 20526559
[No Abstract] [Full Text] [Related]
20. Autoimmune hepatitis triggered by adalimumab and allergic reactions after various anti-TNFα therapy agents in a patient with rheumatoid arthritis.
Petríková J; Jarčuška P; Svajdler M; Pella D; Macejová Z
Isr Med Assoc J; 2015 Apr; 17(4):256-8. PubMed ID: 26040057
[No Abstract] [Full Text] [Related]
[Next] [New Search]